Table 3.

Distribution of disease in patients with non-castrate metastatic prostate cancer

Category	Overall
Patients reviewed	31
Median age (range)	61 (47–79)
Median pretreatment PSA (range)	19.85 (0.63–74.87)
Number of patients with:
Bone only	4 (13%)
Bone and soft tissue	22 (71%)
Soft tissue only	5 (16%)
Patients
No. patients with measurable lesions	12 (39%)
Nodes	10
Visceral	2
No. patients with lesions ≥2 cm	5 (16%)
No. patients with lesions <2 cm	7 (23%)
Lesions
No. measurable lesions	15
No. lesions ≥2 cm	7 (47%)
Lymph nodes	5 (71%)
Pelvic	4
Lymph node (unspecified)	1
Soft tissue	2 (29%)
Liver/other viscera	1
Prostate/prostate bed	1
No. lesions <2 cm	8 (53%)
Lymph nodes	7 (88%)
Pelvic	5
Retroperitoneal	2
Soft tissue	1 (13%)
Prostate/bed	1
Median size of lesions ≥2 cm	2.4 cm (range, 2–3.3)
Median size of lesions <2 cm	1.6 cm (range, 0.9–1.8)